Myriad Genetics (MYGN) Operating Margin (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Operating Margin of 15.32% for Q1 2026, down 52.0% YoY from 31.92% in Q1 2025, and down 463.86% sequentially from 2.72% in Q4 2025.
Myriad Genetics (MYGN) Operating Margin (2009 - 2026) Analysis & Trends
Myriad Genetics has disclosed Operating Margin across 18 years of filings, most recently posting 15.32% for Q1 2026.
- In Q1 2026, Operating Margin fell 52.0% year-over-year to 15.32%; the TTM figure through Mar 2026 stood at 46.91% (down 3194.0% YoY), while the FY2025 annual figure was 46.96%, down 3222.0% from the prior year.
- Operating Margin eased to 15.32% in Q1 2026, from 2.72% in the prior quarter.
- Over the last five years, Operating Margin for MYGN reached as high as 2.72% in Q4 2025 and fell as low as 154.48% in Q2 2025.
- The 5-year median for Operating Margin is 15.97% (2023), against an average of 28.19%.
- Annual changes were most pronounced in 2024 — Operating Margin surged 4470 bps — and 2025, when it slumped 13722 bps.
- A 5-year view of Operating Margin shows it stood at 29.36% in 2022, then jumped by 46 bps to 15.97% in 2023, then decreased by 16 bps to 18.52% in 2024, then jumped by 85 bps to 2.72% in 2025, then sank by 464 bps to 15.32% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 15.32%, 2.72%, and 11.33% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.78% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -13.42% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.74% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 25.23% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -15.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.32% |
| Dec 31, 2025 | -2.72% |
| Sep 30, 2025 | -11.33% |
| Jun 30, 2025 | -154.48% |
| Mar 31, 2025 | -14.80% |
| Dec 31, 2024 | -18.52% |
| Sep 30, 2024 | -9.38% |
| Jun 30, 2024 | -17.26% |
| Mar 31, 2024 | -13.80% |
| Dec 31, 2023 | -15.97% |
| Sep 30, 2023 | -31.32% |
| Jun 30, 2023 | -61.96% |
| Mar 31, 2023 | -28.81% |
| Dec 31, 2022 | -29.36% |
| Sep 30, 2022 | -28.77% |
| Jun 30, 2022 | -9.93% |
| Mar 31, 2022 | -15.52% |
| Dec 31, 2021 | -26.80% |
| Sep 30, 2021 | -47.76% |
| Jun 30, 2021 | -10.98% |